Mark J. Mulligan, MD, FIDSA
Mark J. Mulligan, MD, FIDSA
New York University Vaccine Center
Email verificata su nyulangone.org
Titolo
Citata da
Citata da
Anno
Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans
TD Querec, RS Akondy, EK Lee, W Cao, HI Nakaya, D Teuwen, A Pirani, ...
Nature immunology 10 (1), 116, 2009
9092009
Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection
J Wrammert, D Koutsonanos, GM Li, S Edupuganti, J Sui, M Morrissey, ...
Journal of Experimental Medicine 208 (1), 181-193, 2011
7152011
Efficacy trial of a DNA/rAd5 HIV-1 preventive vaccine
SM Hammer, ME Sobieszczyk, H Janes, ST Karuna, MJ Mulligan, ...
New England Journal of Medicine 369 (22), 2083-2092, 2013
5052013
Human effector and memory CD8+ T cell responses to smallpox and yellow fever vaccines
JD Miller, RG van der Most, RS Akondy, JT Glidewell, S Albott, ...
Immunity 28 (5), 710-722, 2008
5032008
Human antibody responses after dengue virus infection are highly cross-reactive to Zika virus
L Priyamvada, KM Quicke, WH Hudson, N Onlamoon, J Sewatanon, ...
Proceedings of the National Academy of Sciences 113 (28), 7852-7857, 2016
3972016
Magnitude of functional CD8+ T-cell responses to the gag protein of human immunodeficiency virus type 1 correlates inversely with viral load in plasma
BH Edwards, A Bansal, S Sabbaj, J Bakari, MJ Mulligan, PA Goepfert
Journal of virology 76 (5), 2298-2305, 2002
3832002
Magnitude of functional CD8+ T-cell responses to the gag protein of human immunodeficiency virus type 1 correlates inversely with viral load in plasma
BH Edwards, A Bansal, S Sabbaj, J Bakari, MJ Mulligan, PA Goepfert
Journal of virology 76 (5), 2298-2305, 2002
3832002
Molecular signatures of antibody responses derived from a systems biology study of five human vaccines
S Li, N Rouphael, S Duraisingham, S Romero-Steiner, S Presnell, ...
Nature immunology 15 (2), 195-204, 2014
3752014
Pandemic H1N1 influenza vaccine induces a recall response in humans that favors broadly cross-reactive memory B cells
GM Li, C Chiu, J Wrammert, M McCausland, SF Andrews, NY Zheng, ...
Proceedings of the National Academy of Sciences 109 (23), 9047-9052, 2012
3272012
Protection against vaginal SIV transmission with microencapsulated vaccine
PA Marx, RW Compans, A Gettie, JK Staas, RM Gilley, MJ Mulligan, ...
Science 260 (5112), 1323-1327, 1993
3001993
The yellow fever virus vaccine induces a broad and polyfunctional human memory CD8+ T cell response
RS Akondy, ND Monson, JD Miller, S Edupuganti, D Teuwen, H Wu, ...
The Journal of Immunology 183 (12), 7919-7930, 2009
2702009
A significant number of human immunodeficiency virus epitope-specific cytotoxic T lymphocytes detected by tetramer binding do not produce gamma interferon
PA Goepfert, A Bansal, BH Edwards, GD Ritter, I Tellez, SA McPherson, ...
Journal of virology 74 (21), 10249-10255, 2000
2292000
Induction of immune responses to HIV-1 by canarypox virus (ALVAC) HIV-1 and gp120 SF-2 recombinant vaccines in uninfected volunteers
RB Belshe, GJ Gorse, MJ Mulligan, TG Evans, MC Keefer, JL Excler, ...
Aids 12 (18), 2407-2415, 1998
2111998
A Canarypox Vaccine Expressing Multiple Human Immunodeficiency Virus Type 1 Genes Given Alone or with Rgp120 Elicits Broad and Durable CD8+ Cytotoxic T…
TG Evans, MC Keefer, KJ Weinhold, M Wolff, D Montefiori, GJ Gorse, ...
The Journal of infectious diseases 180 (2), 290-298, 1999
1991999
Understanding racial HIV/STI disparities in black and white men who have sex with men: a multilevel approach
PS Sullivan, J Peterson, ES Rosenberg, CF Kelley, H Cooper, A Vaughan, ...
PloS one 9 (3), e90514, 2014
1692014
Safety and immunogenicity of a canarypox-vectored human immunodeficiency virus Type 1 vaccine with or without gp120: a phase 2 study in higher-and lower-risk volunteers
RB Belshe, C Stevens, GJ Gorse, S Buchbinder, K Weinhold, H Sheppard, ...
The Journal of infectious diseases 183 (9), 1343-1352, 2001
1672001
Prolonged detection of Zika virus in vaginal secretions and whole blood
KO Murray, R Gorchakov, AR Carlson, R Berry, L Lai, M Natrajan, ...
Emerging infectious diseases 23 (1), 99, 2017
1652017
Broadly neutralizing activity of Zika virus-immune sera identifies a single viral serotype
KA Dowd, CR DeMaso, RS Pelc, SD Speer, ARY Smith, L Goo, DJ Platt, ...
Cell reports 16 (6), 1485-1491, 2016
1612016
Origin and differentiation of human memory CD8 T cells after vaccination
RS Akondy, M Fitch, S Edupuganti, S Yang, HT Kissick, KW Li, ...
Nature 552 (7685), 362-367, 2017
1572017
QS-21 promotes an adjuvant effect allowing for reduced antigen dose during HIV-1 envelope subunit immmunization in humans
TG Evans, MJ McElrath, T Matthews, D Montefiori, K Weinhold, M Wolff, ...
Vaccine 19 (15-16), 2080-2091, 2001
1552001
Il sistema al momento non pu eseguire l'operazione. Riprova pi tardi.
Articoli 1–20